Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Drug Insights
4 min read
Deep Scientific Insights on Erythromycin Ethylsuccinate's R&D Progress, Mechanism of Action, and Drug Target
26 September 2023
This article summarized the latest R&D progress of Erythromycin Ethylsuccinate, the Mechanism of Action for Erythromycin Ethylsuccinate, and the drug target R&D trends for Erythromycin Ethylsuccinate.
Valuable Targets
5 min read
Analysis on the Clinical Research Progress of cholesterol drug
26 September 2023
Cholesterol, also known as cholesterin, is a derivative of polycyclic hydrocarbon, widely present in animal bodies, especially abundant in brain and neural tissues.
Drug Insights
4 min read
Duvelisib: Detailed Review of its Transformative R&D Success, Mechanism of Action, and Drug Target
26 September 2023
This article summarized the latest R&D progress of Duvelisib, the Mechanism of Action for Duvelisib, and the drug target R&D trends for Duvelisib.
"What" Series
2 min read
What is a CRO in Life Sciences?
26 September 2023
The full name is Contract Research Organization, which is a contract outsourcing service organization for new drug research and development.
Drug Insights
4 min read
Doxercalciferol Unveiled: A Detailed Overview of its Revolutionary R&D Breakthroughs, Mechanisms of Action, and Drug Target
26 September 2023
This article summarized the latest R&D progress of Doxercalciferol, the Mechanism of Action for Doxercalciferol, and the drug target R&D trends for Doxercalciferol.
Valuable Targets
6 min read
Analysis on the Research Progress of IL-6 inhibitors
26 September 2023
Interleukin-6 (IL-6) is a 26-kDa secretory protein composed of 184 amino acids and two N-glycosylation sites, as well as four cysteine residues in the mature IL-6.
Drug Insights
3 min read
Unleashing the Power of Cyclopentolate Hydrochloride: A Comprehensive Review on R&D Breakthroughs
26 September 2023
This article summarized the latest R&D progress of Cyclopentolate Hydrochloride, the Mechanism of Action for Cyclopentolate Hydrochloride, and the drug target R&D trends for Cyclopentolate Hydrochloride.
Latest Hotspot
3 min read
Orchard Therapeutics Declares Approval of Biologics License Application for OTL-200 pertaining to MLD
26 September 2023
Orchard Therapeutics, a renowned leader in gene therapy worldwide, reported that the U.S. FDA has approved the submission of their BLA for OTL-200.
Drug Insights
4 min read
A Comprehensive Review of Cyanamide's R&D Innovations and Drug Target Mechanism
26 September 2023
This article summarized the latest R&D progress of Cyanamide, the Mechanism of Action for Cyanamide, and the drug target R&D trends for Cyanamide.
Bio Sequence
2 min read
Gaining the Competitive Edge: Effective Strategies for Patent Retrieval and Analysis of ADC Drugs
26 September 2023
Kadcyla is an antibody-drug conjugate (ADC) used as a single-agent treatment for HER2-positive metastatic breast cancer patients. The article introduces the specific operational methods for patent retrieval of the ADC drug Kadcyla.
Drug Insights
4 min read
Pharmaceutical Insights: Colestipol Hydrochloride's R&D Progress and its Mechanism of Action on Drug Target
26 September 2023
This article summarized the latest R&D progress of Colestipol Hydrochloride, the Mechanism of Action for Colestipol Hydrochloride, and the drug target R&D trends for Colestipol Hydrochloride.
Latest Hotspot
3 min read
Rani Therapeutics begins Phase 1 trial of RT-111
26 September 2023
Rani Therapeutics Holdings proclaimed the launch of a Phase 1 clinical investigation assessing the safety and tolerability of RT-111.